Enterococcus faecalis is a Gram-positive, facultatively anaerobic coccus that inhabits the gastrointestinal tract, oral cavity, and genitourinary tract of humans. It is a commensal in the healthy gut at low abundance but is one of the most clinically significant opportunistic pathogens, causing urinary tract infections, bacteremia, endocarditis, and surgical site infections — particularly in hospital settings where vancomycin-resistant enterococci (VRE) are a critical public health threat.
From a WikiBiome perspective, E. faecalis is remarkable for two reasons that Wikipedia does not cover well: its role in an interspecies drug-degradation pathway that reduces levodopa efficacy in Parkinson's disease, and its superoxide-mediated DNA damage that contributes to colorectal carcinogenesis. Both mechanisms illustrate how a single commensal-turned-pathogen can influence diseases far removed from traditional infectious disease.
Metal Dependencies
E. faecalis has a sophisticated relationship with metals:
- Manganese: Unlike most bacteria that rely primarily on iron, E. faecalis uses manganese as a key cofactor for superoxide dismutase (MnSOD) and as a substitute for iron in many metabolic enzymes. This manganese-centered metabolism makes it inherently resistant to iron limitation by the host (nutritional immunity).
- Iron: Required for some redox enzymes but not as critical as for most Gram-negatives, contributing to E. faecalis resilience in iron-restricted environments.
- Zinc susceptibility: E. faecalis is susceptible to zinc-enhanced antimicrobial strategies. A zinc-potentiated halogenated phenazine disrupted metal homeostasis in E. faecalis by causing intracellular zinc and iron accumulation, manganese depletion, and ultimately bacterial killing. This mis-metallation mechanism represents a novel antimicrobial approach (kajfasz 2026 zinc enhanced phenazine antimicrobial gram positive, in-vitro).
Key Enzymes and Virulence Factors
- Tyrosine decarboxylase (TyrDC): The enzyme that converts L-DOPA (levodopa) to dopamine in the gut. This is the first step of an interspecies relay where E. faecalis produces dopamine, which is then dehydroxylated to m-tyramine by Eggerthella lenta. The combined pathway significantly reduces levodopa bioavailability in Parkinson's patients. AFMT (alpha-fluoromethyltyrosine) can selectively inhibit bacterial TyrDC without affecting host DOPA decarboxylase (maini rekdal 2019 microbiome drug interactions parkinsons, in-vitro).
- Extracellular superoxide: E. faecalis produces extracellular superoxide and hydrogen peroxide that generate reactive oxygen species (ROS), causing oxidative DNA damage in nearby colonocytes. This mechanism contributes to genomic instability and colorectal carcinogenesis (hanus 2021 immune microbiota metabolites crc triad, expert-opinion).
- Cytolysin: A two-peptide bacteriocin/toxin that lyses eukaryotic cells and is associated with increased disease severity in enterococcal infections.
- Gelatinase (GelE): A metalloprotease that degrades host tissue proteins, facilitating invasion and biofilm maturation.
- Biofilm formation: E. faecalis forms robust biofilms on medical devices and mucosal surfaces, contributing to antibiotic tolerance and chronic infection.
Ecological Role
In the healthy gut, E. faecalis is a minor member of the Firmicutes community, kept in check by competitive exclusion from dominant anaerobes and antimicrobial peptides. It becomes ecologically significant when:
- Antibiotic disruption: Broad-spectrum antibiotics (especially vancomycin, paradoxically) can eliminate competing commensals and allow E. faecalis expansion. In EAE (MS model), E. faecalis did not ameliorate neuroinflammation when administered, confirming it lacks the anti-inflammatory properties of beneficial commensals (bianchimano 2022 vancomycin gut commensals neuroinflammation eae, animal-model).
- Inflammation: Enriched in IBD, particularly UC, where disrupted barrier function and oxidative stress create favorable conditions.
- Reproductive tract dysbiosis: Significantly enriched in the vaginal and intestinal microbiota of women with adenomyosis and infertility (ponomaryova 2022 adenomyosis infertility genital intestinal microbiota, cross-sectional).
Conditions Associated
Enriched in:
- Colorectal cancer: Cataloged as a pro-tumor bacterium through extracellular superoxide/ROS-mediated DNA damage, contributing to genomic instability (hanus 2021 immune microbiota metabolites crc triad, expert-opinion; xu 2022 fmt antitumor cancer immunotherapy, expert-opinion).
- Adenomyosis/infertility: Enriched in vaginal and intestinal microbiota of women with adenomyosis alongside E. coli, S. epidermidis, and Candida (ponomaryova 2022 adenomyosis infertility genital intestinal microbiota, cross-sectional).
- Ulcerative colitis: Markedly elevated in UC patients, distinguishing UC from CD taxonomically (kang 2023 diagnosis crohns uc microbiome, cross-sectional).
- Pancreatic cancer: Found in duodenal microbiota of PC patients (pourali 2024 microbiome biomarker therapeutic target pancreatic cancer, expert-opinion).
Drug interaction:
- Parkinson's disease (levodopa): E. faecalis TyrDC converts L-DOPA to dopamine in the gut, the first step in an interspecies pathway that can account for significant drug loss before systemic absorption. Variability in E. faecalis TyrDC gene carriage among patients explains variable levodopa responses (maini rekdal 2019 microbiome drug interactions parkinsons, in-vitro).
Key Studies
| Study | Finding | Evidence Level |
|---|---|---|
| maini rekdal 2019 microbiome drug interactions parkinsons | TyrDC converts L-DOPA to dopamine; interspecies pathway with E. lenta | In vitro |
| kajfasz 2026 zinc enhanced phenazine antimicrobial gram positive | Zinc-potentiated phenazine kills E. faecalis via mis-metallation | In vitro |
| hanus 2021 immune microbiota metabolites crc triad | Superoxide/ROS-mediated DNA damage in CRC | Expert opinion |
| ponomaryova 2022 adenomyosis infertility genital intestinal microbiota | Enriched in adenomyosis vaginal/intestinal microbiota | Cross-sectional |
| bianchimano 2022 vancomycin gut commensals neuroinflammation eae | Did not ameliorate EAE (negative control) | Animal model |
Cross-References
- eggerthella — interspecies partner in L-DOPA degradation
- parkinsons disease — levodopa bioavailability reduction
- zinc — zinc-enhanced antimicrobial susceptibility
- colorectal cancer — superoxide-mediated carcinogenesis
- antimicrobial resistance — VRE as critical pathogen
- adenomyosis — reproductive tract enrichment
- biofilm — device-associated and mucosal biofilm formation
- manganese — manganese-centered metabolism enabling iron-limitation resistance